Amniotic Membrane Adjuncts and Clinical Applications in Wound Healing: A Review of the Literature
- PMID: 30059334
Amniotic Membrane Adjuncts and Clinical Applications in Wound Healing: A Review of the Literature
Abstract
Introduction: Recent advances in the preservation and processing of amnion/chorion tissue have dramatically increased the bioavailability of these wound healing factors as well as the shelf life of their related tissue products, allowing for a surge in clinical use. Many studies, including basic science, clinical trials, and randomized controlled trials, have emerged examining the biologic properties of amnion/chorion membrane products and their efficacy in wound healing.
Objective: A literature review was conducted regarding the safety and efficacy of amniotic membrane adjuncts.
Methods: The PubMed and MEDLINE databases were queried and sorted based on clinical trials with publication dates ranging from 2013 to 2017. Only studies pertaining to human subjects were included for review.
Results: Amnion/chorion membranes have been studied in the treatment of burns, diabetic foot ulcers, fistulas, ocular defects, and venous leg ulcers, among other wounds. Amnion/chorion allografts were found to be beneficial in the setting of difficult-to-heal fistulas and were effective in treating diabetic and venous ulcers when combined with standard therapy.
Conclusions: Overall, clinical trials have demonstrated that patients treated with amniotic membrane products have increased rates of wound healing compared with the standard of care. Additional trials are needed to examine more amnion/chorion membrane products.
Similar articles
-
Use of Dehydrated Human Amnion/Chorion Membrane Allografts in More Than 100 Patients with Six Major Types of Refractory Nonhealing Wounds.J Am Podiatr Med Assoc. 2018 Mar;108(2):84-89. doi: 10.7547/17-039. J Am Podiatr Med Assoc. 2018. PMID: 29634297
-
Effectiveness and safety of human amnion/chorion membrane therapy for diabetic foot ulcers: An updated meta-analysis of randomized clinical trials.Wound Repair Regen. 2020 Nov;28(6):739-750. doi: 10.1111/wrr.12851. Epub 2020 Aug 11. Wound Repair Regen. 2020. PMID: 32715574
-
A multicentre randomised controlled trial evaluating the efficacy of dehydrated human amnion/chorion membrane (EpiFix® ) allograft for the treatment of venous leg ulcers.Int Wound J. 2018 Feb;15(1):114-122. doi: 10.1111/iwj.12843. Epub 2017 Oct 11. Int Wound J. 2018. PMID: 29024419 Free PMC article. Clinical Trial.
-
The Use of Dehydrated Human Amnion/Chorion Membranes in the Treatment of Burns and Complex Wounds: Current and Future Applications.Ann Plast Surg. 2017 Feb;78(2 Suppl 1):S11-S13. doi: 10.1097/SAP.0000000000000983. Ann Plast Surg. 2017. PMID: 28079550 Review.
-
The use of human amnion/chorion membrane in the clinical setting for lower extremity repair: a review.Clin Podiatr Med Surg. 2015 Jan;32(1):135-46. doi: 10.1016/j.cpm.2014.09.002. Clin Podiatr Med Surg. 2015. PMID: 25440424 Review.
Cited by
-
Conjunctival and Limbal Conjunctival Autograft vs. Amniotic Membrane Graft in Primary Pterygium Surgery: A 30-Year Comprehensive Review.Ophthalmol Ther. 2023 Jun;12(3):1501-1517. doi: 10.1007/s40123-023-00689-x. Epub 2023 Mar 24. Ophthalmol Ther. 2023. PMID: 36961661 Free PMC article. Review.
-
Healing of a chronic ulcer of the lower limb of venous origin with fresh human amniochorionic membrane allograft.Biomedica. 2022 May 1;42(Sp. 1):17-25. doi: 10.7705/biomedica.6319. Biomedica. 2022. PMID: 35866726 Free PMC article. English, Spanish.
-
Acellular Biomaterials Associated with Autologous Bone Marrow-Derived Mononuclear Stem Cells Improve Wound Healing through Paracrine Effects.Biomedicines. 2023 Mar 24;11(4):1003. doi: 10.3390/biomedicines11041003. Biomedicines. 2023. PMID: 37189621 Free PMC article.
-
Preparation of human amniotic membrane for transplantation in different application areas.Front Transplant. 2023 May 5;2:1152068. doi: 10.3389/frtra.2023.1152068. eCollection 2023. Front Transplant. 2023. PMID: 38993896 Free PMC article. Review.
-
Application of the Human Amniotic Membrane as an Adjuvant Therapy for the Treatment of Hepatocellular Carcinoma.Adv Exp Med Biol. 2024;1470:129-146. doi: 10.1007/5584_2023_792. Adv Exp Med Biol. 2024. PMID: 38036871 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical